✦ LIBER ✦

Systemic lupus erythematosus in a patient previously diagnosed as having shulman disease

✍ Scribed by Edward M. Sills

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 261 KB
Volume: 31
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780310519

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Legionnaires' disease in a patient with

Legionnaires' disease in a patient with systemic lupus erythematosus

✍ Ralph F. Jacox; I. Donald Stuard 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 970 KB

Hepatic veno-occlusive disease in a pati

Hepatic veno-occlusive disease in a patient with systemic lupus erythematosus

✍ S. Chris Pappas; Daniel G. Malone; Lionel Rabin; Jay H. Hoofnagle; E. Anthony Jo 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Appearance of Hodgkin's disease in a pat

Appearance of Hodgkin's disease in a patient with systemic lupus erythematosus

✍ Laurance B. Nilsen; Morris E. Missal; John J. Condemi 📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 3 views

Morquio disease in a patient diagnosed a

Morquio disease in a patient diagnosed as having perthes disease for 38 years

✍ S. G. Fang-Kircher; A. Böck; W. Fertschak; W. Schwägerl; E. Paschke 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 122 KB

Immune complex disease consistent with s

Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance

✍ H. Parsons; F. Snyder; T. Bowen; J. Klassen; A. Pinto 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 780 KB

Interleukin–1 receptor antagonist gene p

Interleukin–1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus

✍ Alexandra I. F. Blakemore; Joanna K. Tarlow; Michael J.Cork; Caroline Gordon; Pa 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

We have previously described associations between an allele of the interleukin-1 receptor antagonist gene (ILlRN) and several inflammatory diseases. In this study we tested the ILlRN gene as a possible marker in patients with systemic lupus erythematosus (SLE). Methods. Eighty-one SLE patients and